市場調查報告書

全球分子生物感應器市場:各用途,技術,類型,地區 - 成長,趨勢,預測(2018年∼2023年)

Molecular Biosensors Market - Growth, Trends, Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 391373
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
全球分子生物感應器市場:各用途,技術,類型,地區 - 成長,趨勢,預測(2018年∼2023年) Molecular Biosensors Market - Growth, Trends, Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

全球分子生物感應器市場,預計從2018年到2023年,以7.5%的年複合成長率發展。各地區中,以奈米技術領域的分子生物感應器的用途擴大為背景,北美成為最大市場。

本報告提供全球分子生物感應器市場調查,市場概要,各用途、技術、類型、地區的市場規模的變化與預測,市場趨勢,成長要素、阻礙因素以及市場機會、課題分析,競爭情形,主要企業的簡介等,全面性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第6章 成長要素,阻礙因素,機會,課題分析

  • 市場成長要素
    • 慢性疾病及文明病的盛行率的上升
    • POC檢驗的需求增加
    • 各種產業上生物感應器的應用擴大
  • 市場阻礙因素
    • 生物感應器的嚴格法規必要條件
    • 償付制度的問題
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各用途
    • 醫療診斷
    • 製藥、生物製藥
    • 食品、飲料
    • 環境安全
    • 防衛、安全
    • 其他
  • 各技術
    • 電化學生物感應器
    • 光學生物感應器
    • 熱生物感應器
    • 壓電生物感應器
  • 各類型
    • 生物訊號傳達
    • 傳達要素
    • 認識要素
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 競爭情形

  • 合併及收購分析
  • 協定,合作,夥伴關係
  • 新產品的銷售

第9章 主要業者

  • Abbott Laboratories Inc.
  • Bayer AG
  • F. Hoffmann La Roche
  • Johnson and Johnson
  • LifeSensors Inc.
  • Medtronic Inc.
  • Nova biomedical Corporation
  • Siemens Healthcare

第10章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 48746

A molecular biosensor is a device that uses specific biochemical reactions mediated by isolated enzymes, immunosystems, tissues, organelles or whole cells to detect chemical compounds usually by electrical, thermal or optical signals. Molecular biosensors are, thus, able to facilitate rapid detection and diagnosis at the POC, which make them particularly useful for an early and unequivocal diagnosis, and to prevent further disease spread

In recent years, due to ti increasing prevalence of chronic diseases, demand for point-of-care diagnostics has increased. This has led to an increase in demand for molecular biosensors. The factors have resulted in increased adoption of the molecular biosensor, which has helped the market growth.

However, high costs involved in research and development and strict regulatory guidelines to by authorities dissuade many manufacturers to enter the market. This has hindered the growth rate of the market.

Key Market Trends

Electrochemical Biosensors is Expected to Dominate the Market

Electrochemical biosensors have emerged as reliable molecular sensing devices suitable for the detection of pathogens in liquid biopsies. Short assay time, simple handling, low cost, small sample requirement, the ibility of multiplexing and miniaturization and good performance in complex samples with minimal pre-treatments justify their increasing growing and suitability for POC applications. These biosensors are able to facilitate rapid detection and diagnosis at the POC, which make them particularly useful for an early and unequivocal diagnosis, and to prevent further disease spread.

Pathogens are microorganisms that cause infectious disease. Bacteria and viruses are the main pathogens. Bacteria release toxins, and viruses damage cells. White blood cells destroy pathogens by ingestion or producing antibodies against them and antitoxins to neutralize toxins. Recently, due to unhealthy living conditions, especially in developing and underdeveloped countries, the incidence of bacterial infection has increased. Even in developed countries like the United States, the incidence of campylobacter gram-negative bacteria infection increased from 12.82 in 2004 to 12.97 in 2009 to 13.29 in 2014, according to a 2016 report by the Centers for Disease Control and Prevention.

Hence with increase in infection from pathogens, the demand for fast PoC diagnostics like electrochemical biosensors is expected to increase

North America is Expected to Dominate the Market

The North American countries of the United States (US) and Canada have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the US and Canada. As a result, these countries enjoy the presence of many global market players. As high and increasing demand is met by the presence of global players in the region, the market is further expected to increase.

Competitive Landscape

Majority of the molecular biosensors are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic and Lifestyle Induced Diseases
    • 4.2.2 Increasing Demand for Point of Care Testing
    • 4.2.3 Increasing Application of Biosensors in Various Industries
  • 4.3 Market Restraints
    • 4.3.1 Strict Regulatory Requirements for Biosensors
    • 4.3.2 High Cost Involved in Research and Development
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Electrochemical Biosensors
    • 5.1.2 Optical Biosensors
    • 5.1.3 Thermal Biosensors
    • 5.1.4 Others
  • 5.2 By Application
    • 5.2.1 Medical Diagnostics
    • 5.2.2 Food and Beverages
    • 5.2.3 Environment Safety
    • 5.2.4 Defense and Security
    • 5.2.5 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories Inc.
    • 6.1.2 Dynamic Biosensors GmbH
    • 6.1.3 Bio-Rad Laboratories Inc
    • 6.1.4 F. Hoffmann La Roche
    • 6.1.5 Johnson and Johnson
    • 6.1.6 LifeSensors Inc.
    • 6.1.7 Medtronic Inc.
    • 6.1.8 Nova biomedical Corporation
    • 6.1.9 Siemens Healthcare
    • 6.1.10 Sysmex Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS